Impact of low-intensity electric field therapy on malignant pleural mesothelioma cell proliferation

Therapeutic Protocols

Impact of low-intensity electric field therapy on malignant pleural mesothelioma cell proliferation

A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with...

Therapeutic Protocols

Many malignant pleural mesothelioma (MPM) patients are candidates for chemotherapy with a single agent or in combination with other treatments.

Phase II study on the activity of trabectedin in pretreated epithelioid or biphasic/sarcomatoid malignant pleural...

Therapeutic Protocols

Trabectedin is a drug that binds to the minor groove of DNA, alkylating guanine at the N2 position and with an original mechanism of action involving the nucleotide excision repair machinery.

Bio-immunotherapy of mesothelioma: clinical use of new therapeutic targets.  In vitro data and the first clinical...

Therapeutic Protocols

The clinical study investigating the anti-CTLA-4 human monoclonal antibody (mAb) tremelimumab in the immunotherapy of malignant mesothelioma was initiated in 2009.